This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1995 Dec 2;346(8988):1440-2.

doi: 10.1016/s0140-6736(95)92466-3.

Evidence-based management of dyslipidaemia

R Jackson¹, R Beaglehole

Affiliations

PMID: 7490985
DOI: 10.1016/s0140-6736(95)92466-3

Comment

Evidence-based management of dyslipidaemia

R Jackson et al. Lancet. 1995.

. 1995 Dec 2;346(8988):1440-2.

doi: 10.1016/s0140-6736(95)92466-3.

Authors

R Jackson¹, R Beaglehole

Affiliation

¹ Department of Community Health, Faculty of Medicine and Health Science, University of Auckland, New Zealand.

PMID: 7490985
DOI: 10.1016/s0140-6736(95)92466-3

No abstract available

PubMed Disclaimer

Comment in

Statin therapy and CHD.
Tobert JA. Tobert JA. Lancet. 1996 Jan 13;347(8994):128. doi: 10.1016/s0140-6736(96)90258-5. Lancet. 1996. PMID: 8538331 Clinical Trial. No abstract available.
Implementation of the 4S study in first myocardial infarction.
MacFadyen RJ, Mollon I, Pringle SD, MacDonald TM. MacFadyen RJ, et al. Lancet. 1996 Feb 24;347(9000):551-2. doi: 10.1016/s0140-6736(96)91186-1. Lancet. 1996. PMID: 8596304 No abstract available.

Comment on

Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease.
Haq IU, Jackson PR, Yeo WW, Ramsay LE. Haq IU, et al. Lancet. 1995 Dec 2;346(8988):1467-71. doi: 10.1016/s0140-6736(95)92477-9. Lancet. 1995. PMID: 7490996

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.